CARVER JENNIFER 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Feb 4, 2019
Insider Transaction Report
Form 4
CARVER JENNIFER
Sr. Vice President, Operations
Transactions
- Award
Common Stock
2019-01-31$5.13/sh+1,260$6,464→ 13,589 total - Award
Stock Option (Right to Buy)
2019-01-31+1,260→ 1,260 totalExercise: $6.04Exp: 2029-01-31→ Common Stock (1,260 underlying)
Footnotes (2)
- [F1]These shares were acquired on 01/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.